Volume 87 Issue 9 | p. 22 | Concentrates
Issue Date: March 2, 2009

Nanosys And Harvard License Medical Nanotech

Department: Business

Nanosys and Harvard University's Office of Technology Development have licensed nanowire-related technology to Vista Therapeutics. In return, Harvard and Nanosys earned equity positions in Vista and will receive license and royalty payments. Vista is developing nanowire-based biosensors for the real-time detection of biomarkers associated with organ and tissue damage. Like Nanosys, Vista is a Harvard spin-off company that includes chemistry professor Charles Lieber among its founders.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment